283 related articles for article (PubMed ID: 27424208)
1. The GNA13-RhoA signaling axis suppresses expression of tumor protective Kallikreins.
Teo CR; Casey PJ; Rasheed SA
Cell Signal; 2016 Oct; 28(10):1479-88. PubMed ID: 27424208
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-31 controls G protein alpha-13 (GNA13) expression and cell invasion in breast cancer cells.
Rasheed SA; Teo CR; Beillard EJ; Voorhoeve PM; Zhou W; Ghosh S; Casey PJ
Mol Cancer; 2015 Mar; 14():67. PubMed ID: 25889182
[TBL] [Abstract][Full Text] [Related]
3. Gα12/13 signaling promotes cervical cancer invasion through the RhoA/ROCK-JNK signaling axis.
Yuan B; Cui J; Wang W; Deng K
Biochem Biophys Res Commun; 2016 May; 473(4):1240-1246. PubMed ID: 27084452
[TBL] [Abstract][Full Text] [Related]
4. Gene Expression of Kallikreins in Breast Cancer Cell Lines.
Watrowski R; Castillo-Tong DC; Obermayr E; Zeillinger R
Anticancer Res; 2020 May; 40(5):2487-2495. PubMed ID: 32366393
[TBL] [Abstract][Full Text] [Related]
5. Gα-13 induces C
Lim WK; Chai X; Ghosh S; Ray D; Wang M; Rasheed SAK; Casey PJ
J Biol Chem; 2019 Nov; 294(48):18192-18206. PubMed ID: 31636124
[TBL] [Abstract][Full Text] [Related]
6. Curcumin inhibits LPA-induced invasion by attenuating RhoA/ROCK/MMPs pathway in MCF7 breast cancer cells.
Sun K; Duan X; Cai H; Liu X; Yang Y; Li M; Zhang X; Wang J
Clin Exp Med; 2016 Feb; 16(1):37-47. PubMed ID: 25596714
[TBL] [Abstract][Full Text] [Related]
7. Agonist-induced CXCR4 and CB2 Heterodimerization Inhibits Gα13/RhoA-mediated Migration.
Scarlett KA; White EZ; Coke CJ; Carter JR; Bryant LK; Hinton CV
Mol Cancer Res; 2018 Apr; 16(4):728-739. PubMed ID: 29330286
[TBL] [Abstract][Full Text] [Related]
8. Inactivating mutations in GNA13 and RHOA in Burkitt's lymphoma and diffuse large B-cell lymphoma: a tumor suppressor function for the Gα13/RhoA axis in B cells.
O'Hayre M; Inoue A; Kufareva I; Wang Z; Mikelis CM; Drummond RA; Avino S; Finkel K; Kalim KW; DiPasquale G; Guo F; Aoki J; Zheng Y; Lionakis MS; Molinolo AA; Gutkind JS
Oncogene; 2016 Jul; 35(29):3771-80. PubMed ID: 26616858
[TBL] [Abstract][Full Text] [Related]
9. Kallikreins as microRNA targets: an in silico and experimental-based analysis.
Chow TF; Crow M; Earle T; El-Said H; Diamandis EP; Yousef GM
Biol Chem; 2008 Jun; 389(6):731-8. PubMed ID: 18627289
[TBL] [Abstract][Full Text] [Related]
10. Intracellular signaling pathways regulate hormone-dependent kallikrein gene expression.
Paliouras M; Diamandis EP
Tumour Biol; 2008; 29(2):63-75. PubMed ID: 18515984
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-182 and microRNA-200a control G-protein subunit α-13 (GNA13) expression and cell invasion synergistically in prostate cancer cells.
Rasheed SAK; Teo CR; Beillard EJ; Voorhoeve PM; Casey PJ
J Biol Chem; 2013 Mar; 288(11):7986-7995. PubMed ID: 23329838
[TBL] [Abstract][Full Text] [Related]
12. NRF2 promotes breast cancer cell proliferation and metastasis by increasing RhoA/ROCK pathway signal transduction.
Zhang C; Wang HJ; Bao QC; Wang L; Guo TK; Chen WL; Xu LL; Zhou HS; Bian JL; Yang YR; Sun HP; Xu XL; You QD
Oncotarget; 2016 Nov; 7(45):73593-73606. PubMed ID: 27713154
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway.
Mohammadi-Yeganeh S; Paryan M; Arefian E; Vasei M; Ghanbarian H; Mahdian R; Karimipoor M; Soleimani M
Tumour Biol; 2016 Jul; 37(7):8993-9000. PubMed ID: 26758430
[TBL] [Abstract][Full Text] [Related]
14. G12 signaling through c-Jun NH2-terminal kinase promotes breast cancer cell invasion.
Juneja J; Cushman I; Casey PJ
PLoS One; 2011; 6(11):e26085. PubMed ID: 22087220
[TBL] [Abstract][Full Text] [Related]
15. Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo.
Pillé JY; Denoyelle C; Varet J; Bertrand JR; Soria J; Opolon P; Lu H; Pritchard LL; Vannier JP; Malvy C; Soria C; Li H
Mol Ther; 2005 Feb; 11(2):267-74. PubMed ID: 15668138
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of human kallikrein 10 (KLK10/NES1) by CpG island hypermethylation in breast, ovarian and prostate cancers.
Sidiropoulos M; Pampalakis G; Sotiropoulou G; Katsaros D; Diamandis EP
Tumour Biol; 2005; 26(6):324-36. PubMed ID: 16254462
[TBL] [Abstract][Full Text] [Related]
17. Antimetastatic effect of salvicine on human breast cancer MDA-MB-435 orthotopic xenograft is closely related to Rho-dependent pathway.
Lang JY; Chen H; Zhou J; Zhang YX; Zhang XW; Li MH; Lin LP; Zhang JS; Waalkes MP; Ding J
Clin Cancer Res; 2005 May; 11(9):3455-64. PubMed ID: 15867248
[TBL] [Abstract][Full Text] [Related]
18. Parallel overexpression of seven kallikrein genes in ovarian cancer.
Yousef GM; Polymeris ME; Yacoub GM; Scorilas A; Soosaipillai A; Popalis C; Fracchioli S; Katsaros D; Diamandis EP
Cancer Res; 2003 May; 63(9):2223-7. PubMed ID: 12727843
[TBL] [Abstract][Full Text] [Related]
19. Activation of choline kinase by extracellular Ca2+ is Ca(2+)-sensing receptor, Galpha12 and Rho-dependent in breast cancer cells.
Huang C; Hydo LM; Liu S; Miller RT
Cell Signal; 2009 Dec; 21(12):1894-900. PubMed ID: 19716891
[TBL] [Abstract][Full Text] [Related]
20. Parallel underexpression of kallikrein 5 and kallikrein 7 mRNA in breast malignancies.
Li X; Liu J; Wang Y; Zhang L; Ning L; Feng Y
Cancer Sci; 2009 Apr; 100(4):601-7. PubMed ID: 19453546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
